Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
a Phase III study compared the two products in RA not sufficiently controlled by methotrexate in order to establish equivalent efficacy and comparable pharmacokinetic, safety and immunogenicity profiles
For a given molecule, the platform shows all Orange Book-listed patents with expiry dates, all active Paragraph IV certifications and the identity of the filers, the litigation status of each P-IV challenge, any known settlement events, the regulatory exclusivity periods active for the product, and the ANDA/biosimilar pipeline
However, there is currently no universally accepted clinical guideline recommending that every patient should cycle on and off treatment
Alhazmi, H
US$ 25.05
US$ 24.10
US$ 22.66
US$ 23.69
